The company usually posts poor financials for mid or long term investments.
The company has poor fundamentals for a short-term investment strategy.
Strengths
Over the last seven days, analysts have been revising upwards their EPS estimates for the company.
Weaknesses
The stock is close to a major daily resistance at EUR 96.24, which should be gotten rid of so as to gain new appreciation potential.
According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
The company sustains low margins.
Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
For the past year, analysts have significantly revised downwards their profit estimates.
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
